@article{TEXTUAL,
      recid = {14509},
      author = {Witkowski, Piotr and Wojcik, Nicole and Appelbaum, Nathan  and Fung, John J. and Barth, Rolf N. and Ricordi, Camillo},
      title = {Demise of cadaveric islet transplantation in the USA: Quo  Vadis, 1 year after BLA approval and 24 years after the  Edmonton breakthrough?},
      journal = {Frontiers in Transplantation},
      address = {2025-01-29},
      number = {TEXTUAL},
      abstract = {More than a year after the Biological License Application  (BLA) approval for CellTrans, cadaveric islet  transplantation remains in demise in the United States  (U.S.). While the therapy is unavailable to Americans, it  is already a standard of care procedure in other countries,  including Canada, Australia, and many in Europe. This  article discusses the challenges stemming from an outdated  regulatory framework in the U.S. concerning cadaveric islet  transplantation. It also presents advocacy efforts by the  transplant community for appropriate regulatory adjustments  and discusses future perspectives.},
      url = {http://knowledge.uchicago.edu/record/14509},
}